Systematic pan-cancer analysis identifies DNASE2 as a potential prognostic marker and immunotherapeutic target for glioblastoma multiforme

Systematic pan-cancer analysis identifies DNASE2 as a potential prognostic marker and immunotherapeutic target for glioblastoma multiforme

Saved in:

Bibliographic Details
Main Authors:	Jun Cao, Si Chen, Ping An, Xingqiang Wang, Xinru Xiao, Shichao Li, Ye Cheng
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2025-07-01
Series:	Genes and Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352304224002289
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comprehensive analysis reveals CLDN9 is a new biomarker in human cancers and immunotherapeutic target for glioblastoma multiforme
by: Yuanyuan Zhu, et al.
Published: (2025-06-01)

Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of PDGFB
by: Bai Y, et al.
Published: (2025-01-01)

Glioblastoma multiforme
by: Melissa Serra Ruíz, et al.
Published: (2019-04-01)

Glioblastoma Multiforme
by: Jonas M. Sheehan, et al.
Published: (2012-01-01)

Advances in Immunotherapy for Glioblastoma Multiforme
by: Boyuan Huang, et al.
Published: (2017-01-01)

Prognostic relevance of cytochrome C oxidase in primary glioblastoma multiforme.
by: Corinne E Griguer, et al.
Published: (2013-01-01)

Targeted Sensitization of Glioblastoma Multiforme Using AAAPT Technology
by: Megan Mendieta, et al.
Published: (2023-01-01)

Comprehensive bioinformatics analysis identified HMGB3 as a promising immunotherapy target for glioblastoma multiforme
by: Libin Wang, et al.
Published: (2025-04-01)

Cerebellar glioblastoma multiforme in an adult
by: João Paulo Mattos, et al.
Published: (2006-03-01)

Pan-cancer analysis reveals MTTP as a prognostic and immunotherapeutic biomarker in human tumors
by: Wenjia Wang, et al.
Published: (2025-03-01)

Lipidic and Inorganic Nanoparticles for Targeted Glioblastoma Multiforme Therapy: Advances and Strategies
by: Ewelina Musielak, et al.
Published: (2025-01-01)

MicroRNA–target cross-talks: Key players in glioblastoma multiforme
by: Eman Ali Toraih, et al.
Published: (2017-11-01)

Glioblastoma Multiformе Tumour Stem Cells as Potential Therapeutic Targets
by: O. A. Beylerli, et al.
Published: (2019-11-01)

Emerging treatment strategies for glioblastoma multiforme
by: Steven K Carlsson, et al.
Published: (2014-10-01)

Comprehensive Pan-Cancer Analysis Identifies IGFL1 as an Oncogenic Biomarker and Immunotherapeutic Target with Experimental Validation in Bladder Cancer
by: Liang Z, et al.
Published: (2025-07-01)

Characterization and prognostic of CD8 + TIM3 + CD101 + T cells in glioblastoma multiforme
by: Hong-Liang Wang, et al.
Published: (2025-05-01)

The role of complete exomic sequencing in the administration of targeted drugs in patients with multiform glioblastoma
by: A. V. Kaminskiy, et al.
Published: (2023-06-01)

Molecular mechanisms and therapeutic targets in glioblastoma multiforme: network and single-cell analyses
by: Xiangyu Chen, et al.
Published: (2025-03-01)

Cellular-Based Immunotherapies for Patients with Glioblastoma Multiforme
by: Xun Xu, et al.
Published: (2012-01-01)

Glioblastoma multiforme: A rare case of GBM
by: Albert Paul Varghese, et al.
Published: (2024-10-01)

Immunological Insights into Photodynamic Therapy of Glioblastoma Multiforme
by: Paweł Woźnicki, et al.
Published: (2025-07-01)

The therapeutic potential of curcumin for the treatment of glioblastoma multiforme
by: T. I. Kushnir, et al.
Published: (2020-03-01)

Wnt-signaling pathway in pathogenesis of glioblastoma multiforme
by: Yu. D. Vasilets, et al.
Published: (2019-01-01)

Tumor stem cells from glioblastoma multiforme
by: Z. N. Nikiforova, et al.
Published: (2016-06-01)

Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment
by: Christopher Jackson, et al.
Published: (2011-01-01)

Genome-wide methylation analyses in glioblastoma multiforme.
by: Rose K Lai, et al.
Published: (2014-01-01)

Glioblastoma multiforme of the pineal region: case report
by: Emerson Leandro Gasparetto, et al.
Published: (2003-06-01)

Practice Patterns for Managing Recurrent Glioblastoma Multiforme
by: Jitin Bajaj, et al.
Published: (2024-03-01)

Cerebellar glioblastoma mutiforme in an adult Glioblastoma multiforme cerebelar em adulto
by: Carlos A.F. Lobão, et al.
Published: (2008-12-01)

Glioblastoma multiforme no cerebelo: registro de um caso
by: Roberto Aidar Aun, et al.
Published: (1981-09-01)

Pediatric glioblastoma multiforme: A single-institution experience
by: Mansour Ansari, et al.
Published: (2012-01-01)

Kaposi’s sarcoma occurring in a glioblastoma multiforme on temozolomide
by: Jiong-Huang Lim, et al.
Published: (2025-01-01)

The effect of hypoxia on the secretome of human glioblastoma multiforme cells
by: T. I. Kushnir, et al.
Published: (2021-05-01)

Glioblastoma Multiforme in the Cerebellopontine Angle in a Pediatric Patient
by: Ivethe Pregúntegui-Loayza, et al.
Published: (2021-08-01)

Methuosis key gene ARF6 as a diagnostic, prognostic and immunotherapeutic marker for prostate cancer: based on a comprehensive pan-cancer multi-omics analysis
by: Yongjin Yang, et al.
Published: (2025-05-01)

Pan-cancer analysis shows that BCAP31 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types
by: Yangyong Sun, et al.
Published: (2024-12-01)

SPP1 as a Prognostic and Immunotherapeutic Biomarker in Gliomas and Other Cancer Types: A Pan-Cancer Study
by: Wang K, et al.
Published: (2025-02-01)

Advanced Targeted Therapeutic Strategies for Glioblastoma Multiforme: Bevacizumab and Its Emerging Nanotechnology-Based Interventions
by: Soner Şahin, et al.
Published: (2024-12-01)

A multi-omics target study for glioblastoma multiforme (GBM) based on Mendelian randomization analysis
by: Hao Sun, et al.
Published: (2025-06-01)

Metástases intrarraquidianas de glioblastoma multiforme supratentorial da infância: relato de caso Spinal cord metastatic glioblastoma multiforme of childhood: case report
by: Patricia Imperatriz Porto Rondinelli, et al.
Published: (2002-09-01)